Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3663965 A
Publication typeGrant
Publication dateMay 23, 1972
Filing dateJun 8, 1970
Priority dateJun 8, 1970
Publication numberUS 3663965 A, US 3663965A, US-A-3663965, US3663965 A, US3663965A
InventorsGordon W Culp, Henry L Lee Jr, David E Ocumpaugh
Original AssigneeGordon W Culp, David E Ocumpaugh, Henry L Lee Jr
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Bacteria-resistant percutaneous conduit device
US 3663965 A
Abstract
A percutaneous device for facilitating passage of wires, tubes, and other electrical or fluid conductors through the skin of an animal, in a manner such that the wires, tubes, or other conductors are immobilized with respect to the skin and a fluid and bacterial seal is obtained. The device comprises a generally cylindrical, elongated percutaneous conduit element having a central passageway therethrough and a subcutaneous fenestrated flange disposed in generally surrounding relationship to the conduit element. The subcutaneous flange is provided with a series of holes suitably spaced and sized to facilitate growth of tissue therethrough. The conduit element and the flange are contoured to facilitate the proliferation of the external epidermis down along the outer surfaces of the conduit, out, over and under the surfaces of the subcutaneous flange, through the holes in the flange, and up the passageway in the conduit element. Thus, the epidermis provides, in effect, an exteriorization of the flange and a sphincter around the passageway to immobilize wires, tubes and other electrical or fluid conductors extending through the passageway.
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent Lee,-Jr. et al.

[is] 3,663,965 [451 May 23, 1972 [54] BACTERIA-RESISTANT PERCUTANEOUS CONDUIT DEVICE [22] Filed: June 8, 1970 [21] Appl.No.: 44,166

[52] [1.8. CI.., ..3/l, 128/1 R, 12812 R,

, 128/214 R, 128/348, 128/350 R [51] Int. Cl. ..A6lf 1/00, A6lm 25/00 [58] Field ofSearch ..128/348-35l,214 R,

[56] References Cited UNITED STATES PATENTS 3,402,710 9/ 1968 Paleschuck ..l28/1 1,810,466 6/1931 Deutsch 1 28/348 3,461,869 8/1969 Hargest... 128/214 R 3,447,161 6/1969 Weikel ..128/334 C X 3,540,451 11/1970 Zeman ..128/334 C OTHER PUBLICATIONS Merrill et al. Trans. Amer. Soc. Artific. Inter. Orgs. Vol, VII],

pp. 252- 25s, 1962 Ore et a1. Surgery, v01. 52, No. 2, August, 1962 pp. 385 390 Primary Examiner-Dalton L. Truluck Attorney-Irons, Sears, Staas, Halsey & Santorelli ABSTRACT A percutaneous device for facilitating passage of wires, tubes, and other electrical or fluid conductors through the skin of an animal, in a manner such that the wires, tubes, or other conductors are immobilized with respect to the skin and a fluid and bacterial seal is obtained. The device comprises a generally cylindrical, elongated percutaneous conduit element having a central passageway therethrough and a subcutaneous fenestrated flange disposed in generally surrounding relationship to the conduit element. The subcutaneous flange is provided with a series of holes suitably spaced and sized to facilitate growth of tissue therethrough. The conduit element and the flange are contoured to facilitate the proliferation of the external epidemiis down along the outer surfaces of the conduit, out, over and under the surfaces of the subcutaneous flange, through the holes in the flange, and up the passageway in the conduit element. Thus, the epidermis provides, in effect, an exteriorization of the flange and a sphincter around the passageway to immobilize wires, tubes and other electrical or fluid conductors extending through the passageway.

5 Claims, 3 Drawing figures Patented Ma 23, 1972 INVENTORS w w S RPH n w M uC /m .P T A L Y MW J R m m V A BACTERIA-RESISTANT PERCUTANEOUS CONDUIT DEVICE The invention described herein was made in the course of work under a grant or award from the Department of Health, Education and Welfare.

BACKGROUND OF THE INVENTION:

1. Field of the Invention The present invention relates to percutaneous conduit devices and particularly to percutaneous connectors adapted to provide repeated access to internal regions of the body to facilitate such operations, for example, as hemodialysis.

2. Description of the Prior Art The prior art is replete with examples of percutaneous devices. In particular, percutaneous devices have been utilized to provide artificial corneal implants. Examples of these devices are illustrated in U.S. Pat. Nos. 2,714,221 and 3,458,870. These devices, of course, are not conduit devices.

Prior art percutaneous conduit devices are exemplified in U.S. Pat. Nos. 3,447,161; 3,452,366; and 3,461,869. These devices provide, for example, access for pressure and electrical connections for heart pump systems and access to blood vessels for procedures such as peritoneal dialysis, lymph dialysis, and hemodialysis.

The prior art devices commonly have failed to provide adequate sealing from the standpoint of preventing ingress of bacteria and egress of body fluids through and around the percutaneous device. Of course, inadequate sealing presents the potential problem of sinus tract infection from the skin surface downward along the cannulae into the blood, itself, causing septicemia. Such infections, in addition to complicating medical management, necessitate repositioning of the cannulae thereby presenting increased surgical difficulties as the supply of suitable vessels is progressively diminished.

Prior art devices also have been noted for their relatively short life expectancy resulting from trauma applied to vascular walls by movement of the cannulae tips positioned within them. The traumatized vessel walls are active sites for the formation of blood clots and phlebitis, and with time, such complications will also require repositioning of shunts and the like.

The most severe problem encountered in the use of prior art percutaneous devices has been the failure of such devices to resist extrusion from the body. Typically, this phenomena has been encountered because the geometrical configuration of prior art devices has been inadequate to properly anchor the devices within the epidermal epithelium.

SUMMARY OF THE INVENTION The object of the present invention is to avoid the shortcomings of the prior art, and in particular, those which have been discussed above. Primarily, this result has been accomplished by providing a percutaneous device having a configuration suitable for being securely anchored within the epidermal epithelium while maintaining a seal adequate to prevent ingress of bacteria and egress of body fluids and without causing severe trauma to tissues adjacent to the device.

According to the present invention, there is provided a percutaneous conduit device for facilitating passage of information, energy or material to or from the interior of an animal while preventing substantial ingress of bacteria and egress of body fluids. The percutaneous device of this invention comprises an elongated, generally cylindrical percutaneous conduit element having a central passageway therethrough. The device further comprises a subcutaneous fenestrated flange mounted on the conduit element, in surrounding relationship to the passageway. The fenestrations or holes in the flange are spaced and sized to facilitate growth of skin tissue therethrough. The outer surfaces of the conduit element and the flange are contoured to facilitate and guidethe proliferation of the external epidermis of an animal in which said device has been implanted in a direction down along the conduit, out, over and under the flange, through the fenestrations in the flange, and up to said passageway for immobilizing a tube, wire or other electrical or fluid conductor extending through the passageway.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a perspective view of a percutaneous conduit device constructed in accordance with the concepts and principles of the instant invention;

FIG. 2 is a cross-sectional view of the device in position in the skin after surgical implantation; and

FIG. 3 is a top plan view of a preferred embodiment of the device illustrating the manner in which the holes in the fenestrated flange are arranged to achieve a constant ratio of open area to total flange area.

DESCRIPTION OF THE PREFERRED EMBODIMENT The device described herein allows the passage of wires and tubes through the skin of a living animal while precluding egress of body fluids and ingress of bacteria through and around the device.

The puncture sealing skin conduit device may comprise a plurality of component parts which may be constructed individually and later assembled. Conversely, the device may comprise an integral assembly or a plurality of subassemblies. A preferred form of the device, wherein the components are integral, is shown in FIG. 1.

In FIG. 2, it can be seen that the device has a subcutaneous flange l implantable beneath the skin of an animal. Flange l is contiguous with the internal portion 2a of a percutaneous conduit 2. Percutaneous conduit 2 also has a central portion 2b disposed to be located in the subcutaneous tissue and to extend therethrough, and an external portion 20 adapted to be disposed outside the skin of the animal. The device may also include an extracutaneous flange 3 contiguous with external portion 21: of percutaneous conduit 2.

A connecting element 4 is provided for carrying information, energy and/or material to or from the interior of the animal. For this purpose, connecting element 4 extends through conduit 2 as illustrated. Passage of body fluids from within the animal to its exterior and passage of bacteria from the exterior to the interior of the animal, by way of the path between the exterior surface of the connecting element 4 and the interior surface of the conduit 2, is prevented by compression of the conduit 2 around the connecting element 4, and/or by the application of a sealing adhesive 5 at the junction of the connecting element 4 and the extracutaneous flange 3.

Subcutaneous flange l is fenestrated to present a plurality of circular holes 6 therethrough. Holes 6 preferably have transversely rounded edges 6a as can best be seen in FIG. 2. The peripheral edge 7 of subcutaneous flange I is also preferably rounded with a radius equal to approximately one half of the thickness of the subcutaneous flange l. The junction 8 between percutaneous conduit 2 and subcutaneous flange l is also preferably rounded to provide a smoothly contoured fillet radius at junction 8.

FIG. 2 illustrates a cross section of the puncture sealing skin conduit as it appears in the skin after surgical implantation. The epidermal epithelium (stratum corneum to stratum ger minatinum 9),-has been surgically punctured or otherwise modified to implant the device. Because of the novel configuration of the device of this invention, the epidermal epithelium heals by growing inwardly along the exterior cylindrical surface of conduit 2, then along the rounded surface of junction 8 between percutaneous conduit 2 and subcutaneous flange l, thereafter through the holes 6 in subcutaneous flange 1 nearest the conduit 2, and finally along the lower surface In of subcutaneous flange 1 until connecting element 4 is completely surrounded thereby. Note that the epithelium, in effect, forms a sphincter 11 around element 4 to substantially immobilize the latter against movement internally of the host. The epithelium 9 proliferates across both the upper lb and lower la planar surfaces of subcutaneous flange 1 simultaneously with the proliferation of the same through the holes 6 closest to conduit 2. The final stage of growth of the epithelium 9 occurs when the remaining holes 6 in flange l are filled and peripheral edge 7 of subcutaneous flange 1 is surrounded by epithelium 9.

Fabrication of the devices of this invention may be effected by machining separate parts or the entire device from larger fragments of the desired materials. If the parts are fabricated separately, the component parts may be assembled using heat, adhesive, with or without heat, screw threads or deformable fasteners. As an alternative method, the assembly can be accomplished by molding one of the components of the device in a mold in which the other components have been previously, and by design, positioned, such that when the molded component achieves the desired physical properties during the molding process, the molded component and the previously positioned components in the mold become a single assembly and unit.

The percutaneous conduit 2 may or may not be fabricated as a separate component from the extracutaneous flange 3 and/or the subcutaneous flange l. The extracutaneous flange 3 and subcutaneous flange 1 may be cast, molded, or machined as separate components and then assembled to the other component or components of the assembled device.

The subcutaneous flange 1 may preferably be fabricated by cutting a disk from a sheet of the desired material, and then forming the holes 6 therein by punching, shearpunching, drilling, trephining, piercing or otherwise machining. The holes 6 in the subcutaneous flange 1 may alternatively be formed as the flange l is molded, pressed, extruded, or otherwise formed or deformed, using starting materials in gaseous, liquid or solid form, into the desired configuration, by dies, molds, forming tools, cores, patterns, or templates.

The arrangement of the holes 6 in the subcutaneous flange 1 is preferably such that the average open area of the holes 6 per unit area of flange 1 is substantially constant throughout the area of flange 1. As an acceptable alternative, the average open area of the holes 6 per unit area of flange 1 may vary uniformly radially outward from percutaneous conduit 2 to peripheral edge 7 of subcutaneous flange 1. Fabrication of subcutaneous flange 1 with the average open area of the holes 6 per unit area of flange 1 being maintained substantially constant throughout the entire area of flange 1 from the edge of the annular row of holes 6 closest to the percutaneous conduit 2, to peripheral edge 7 of flange 1, may be accomplished, for example, by using a rack and pinion jig in which the pitch diameter of the pinion is made equal to the center circle diameter of the annular, inner rows of holes 6. In this operation, the pitch of the teeth of the pinion gear should be equal to the center-to-center distance of two adjacent holes 6 of the annular inner rows of holes 6 and the hole locating device (in the case of a mold, template, or pattern) or hole forming device (in the case of drilled, punched, trephined, or otherwise formed hole by the process of removing or deforming the material of the flange), is held stationary while the pinion gear, upon which the flange l is positioned, is moving along the rack, thereby causing simultaneous translation and rotation of the flange 1, relative to the hole forming or locating device. The resulting layout of holes is illustrated in FIG. 3.

The geometry of this method is such that the locus of hole forming or locating device positions is an involute spiral which has a base circle equal in diameter to the diameter of the center circle of the annular inner row of holes 6. This geometry therefore requires, when the holes 6 are spaced equidistant along each of the equally spaced involute spiral arms, that the average open area of holes 6 per unit area of flange 1 be constant, since each equally spaced involute spiral arm is everywhere parallel to the adjacent arm. This is true at all locations along the arm from the base circle, where all arms are parallel to a radius of the base circle, to infinity, where all arms are perpendicular to an infinitely extended radius of the base circle. In other words, since the spiral arms are equally spaced, and the holes 6 are equally spaced along each arm, then the average open area of holes 6 per unit area of flange l is constant. This an analogous to wrapping an equally spaced rectilinear array of holes around an axis and distorting the inner-hole topology rather than distorting the topology of the space including the holes.

Holes 6, having rounded edges at both upper and lower planar surfaces of subcutaneous flange l, invoke less irritation to the subcutaneous tissues than would holes having sharp edges. Fabrication of holes having rounded edges may be accomplished by deforming the edges of holes 6 during or after the forming of each hole 6, by removing material comprising the edges of each hole 6 by cutting or scraping, or by molding or forming the holes 6 in a mold or with a die that has provisions for preventing the formation of holes with sharp edges. It has been found that earliest maturation of connective tissue in holes 6 occurs when the diameter of each hole 6 is made approximately equal to the thickness of subcutaneous flange l.

Devices embodying the concepts of this invention may be fabricated from a variety of materials matching the physical characteristics of each device to any one of a variety of applications. The materials found best suited for device fabrication are TFE Teflon (R), silicone rubber, polypropylene, polyurethane, epoxy, and various forms of pyrolyzed carbon. Materials with higher elastic moduli may preferably be used for the subcutaneous flange 1 where the device is to be implanted at a location on the animal where the mobility of the skin is minimal. On the other hand, where the mobility of the skin is high, materials having a lower elastic moduli are preferred for the subcutaneous flange 1 so that erosion of tissues adjacent to the edge 7 of the subcutaneous flange l is minimized by the higher compliance of the latter.

After the device has been implanted, final growth and cessation of the healing process will be characterized by the complete coverage of all of the subcutaneous and percutaneous surfaces of the device with epithelium. Also, in the absence of severe mechanical trauma, the appearance of the tissues adjacent to the device will return to normal, when examined by standard histological techniques, that is by: (a) excision of the device and adjacent skin; (b) sectioning with a microtome; (c) slide preparation; (d) staining with suitable preferential coloring stains; and finally (e) examination of the slides through a microscope.

The epithelium, having covered all subcutaneous and percutaneous surfaces of the device, completely isolates subcutaneous tissues from the foreign material of the device itself and thereby reduces foreign body reactions by the subcutaneous tissues.

In the absence of severe mechanical trauma, the rounded, smooth contour of the surface of the device at the junction 8 between the percutaneous conduit 2 and the subcutaneous flange 1, being completely covered by the epithelium, provides a long, tortuous, labyrinth type path through which bacteria are required to pass before entering the subcutaneous regions. Thus, such bacteria will be subjected to the naturally occurring bacteriostatic and bacteriacidal agents of the epithelium to thereby minimize the possibility that a multiplying colony of bacteria will be established in the subcutaneous tissues adjacent to the device.

The growth of subcutaneous connective tissue through the holes 6 in subcutaneous flange 1, during the latter stages of the healing process, results in the firm enmeshing of the device in the tissue. Accordingly, the device and the adjacent tissues are capable of resisting considerable mechanical force without dislodging the device or otherwise disrupting the adjacent tissues.

The holes 6 in the subcutaneous flange 1 permit free passage of normal body electrolytes and fluids, thereby providing for nutrition of subcutaneous tissues 10 lying between the surface of the skin and the upper surface lb of the subcutaneous flange 1. These holes 6 also facilitate proper removal of waste products of skin metabolism from tissues 10.

The percutaneous conduit 2 of this invention provides for the passage of connecting element(s), such as 4, from the interior of an animal to its exterior while precluding entrance of bacteria into the animal and passage of fluids from within the animal to its exterior.

Mechanical forces applied to the connecting element 4 are transferred through the percutaneous conduit 2 to the subcutaneous flange 1. Thus, such forces are distributed to the epithelial and subcutaneous connective tissues lying in the holes 6 of the subcutaneous flange 1 to thereby minimize the deletorious effects of the mechanical forces on the tissues adjacent to the junction of the skin and the percutaneous conduit 2. This minimizes the possibility that the tissues will be disrupted sufficiently to cause distension of the tissues with the consequent allowance of entrance of bacteria or escape of body fluids.

The extracutaneous flange 3 is disposed to prevent the epithelium 9 of the skin from proliferating such that the exterior portion of the device becomes covered, when, during the initial healing of the skin puncture, the skin adjacent to the percutaneous conduit 2 is swollen because of edema due to subclinical infection, post operative mechanical trauma, surgical trauma, or other causes. Manifestly, such swelling could elevate the epithelial layer 9 to a position above the device and, in the absence of the extracutaneous flange 3, a path would be provided along which epithelial proliferation could occur with great rapidity. This would interfere with proper epithelial proliferation in the desired downward direction along the exterior cyclindrical surfaces of the subcutaneous portions 2a and 2b of the percutaneous conduit 2.

The characteristics discussed above will be achieved with the puncture sealing skin conduit in the living animal if proper surgical and clinical techniques are utilized. These techniques include, inter alia, the following:

A. Implantation of the device using adequate surgical technique and sterile implements;

B. Implantation of the device using sharp and well controlled cutting instruments so that trauma to the skin of the animal is minimized;

C. Isolation of the device and adjacent tissues from interior and exterior mechanical, chemical, and bacteriological trauma until the aforementioned functional characteristics are observed to have occurred; and

D. Protection of the device and adjacent tissues from mechanical, chemical, and bacteriological trauma even after the aforementioned functional characteristics have been fully developed if the level of such trauma is as great as or greater than that which can be sustained without damage by the normal, intact skin.

The bacteria-resistant percutaneous conduit device of this invention may be used whenever it is desirous to pass electric, hydraulic, thermal, or pneumatic energy through the skin of a living organism, or to gain, for any other reason, access to the organism, without the escape of material from within the organism, or invasion of the organism by foreign matter, be it either animate or inanimate.

The device is usable as a container and conduit for single and multi-conductor electrical, pneumatic, hydraulic, optical or thermal circuit connectors. Such connectors may be positioned in the device before or after fabrication, or before or after surgical implantation of the device in the animal. Altemately, the device may have a removable plug, appropriately designed for the necessary bacterial and fluid seal, so that periodic access to the interior of the organism is possible without disrupting the tissues adjacent to the device, or without resorting to additional surgical trauma to the organism to achieve said access. Visual access may be attained through the use of a device having a suitable window fabricated therein as an integral part of the assembly or as a replacement of the previously mentioned plug.

Specifically, providing access for powering a heart assist device or a total mechanical heart replacement, or for the leads of a pacemaker are among the specific uses of the device. As a circulatory access device the percutaneous conduit device is useful for the admission and exit of blood cannulae to allow the connection of the circulatory system to an artifical kidney or an artificial lung or both. Access to the peritoneal cavity may be provided by the percutaneous conduit device for the periodic administration of the peritoneal dialysis. The percutaneous conduit may also be used for the exteriorization of brain electrodes, nerve electrodes, blood pressure, flow, pl-l, pCO p0 and temperature transducers, which may be used to provide information for the control systems of various external adnexa or prosthetic organs.

We claim:

1. A percutaneous conduit device for facilitating passage of information, energy or material to or from the interior of an animal while preventing substantial ingress of bacteria and egress of body fluids, said device comprising:

an elongated, generally cylindrical percutaneous conduit element having a central passageway therethrough; and

a subcutaneous fenestrated flange mounted on the conduit element, in surrounding relationship to said passageway, the holes being dispersed throughout the flange area, being generally circular and having diameters approximately equal to the thickness of the flange and being spaced equidistant along a series of equally angularly spaced involute spirals;

the junction between the outer surfaces of said conduit element and said flange being rounded to provide a smoothly contoured fillet radius to facilitate and guide the proliferation of the external epidermis of an animal in which said device has been implanted in a direction down along the conduit, out, over and under the flange, through the fenestrations in the flange, and up to said passageway whereby said epidermis provides an exteriorization of the flange and a sphincter around said passageway.

2. A percutaneous device as set forth in claim I wherein the total open area of the holes is approximately equal to the remaining area of the flange.

3. A percutaneous device as set forth in claim 1 wherein the lateral edges of the holes and of the flange are rounded.

4. A percutaneous device as set forth in claim 1 wherein said conduit element and said flange are integral.

5. A percutaneous device as set forth in claim 1 wherein is included an external flange disposed at the opposite end of the conduit element from said subcutaneous flange.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1810466 *May 8, 1929Jun 16, 1931Josef DeutschDevice for giving access to cavities of the animal and human body
US3402710 *Jun 27, 1966Sep 24, 1968Hydra Power CorpSelf-closing valve device for implantation in the human body
US3447161 *Aug 1, 1966Jun 3, 1969Avco CorpDisinfectant dispensing percutaneous connector
US3461869 *Apr 5, 1966Aug 19, 1969Bio Medical Systems IncPermanent skin exit device
US3540451 *Feb 28, 1967Nov 17, 1970William V ZemanDrainage cannula with tissue connecting assemblies on both ends
Non-Patent Citations
Reference
1 *Merrill et al. Trans. Amer. Soc. Artific. Inter. Orgs. Vol. VIII, pp. 252 255, 1962
2 *Ore et al. Surgery, Vol. 52, No. 2, August, 1962 pp. 385 390
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3752162 *Apr 10, 1972Aug 14, 1973Dow CorningArtificial cutaneous stoma
US3765032 *Sep 27, 1972Oct 16, 1973J PalmaImplant
US3783868 *May 6, 1971Jan 8, 1974Gulf Oil CorpPercutaneous implant
US3805770 *Jul 18, 1972Apr 23, 1974Olympus Optical CoEndoscope guide and lubricating means
US3852832 *Oct 24, 1972Dec 10, 1974Heyer Schulte CorpProsthesis with fixation means
US3853126 *Nov 15, 1973Dec 10, 1974Heyer Schulte CorpArtery-to-vein shunt
US3964470 *Jul 25, 1974Jun 22, 1976Medtronic, Inc.Percutaneous intradermal electrical connection system and implant device
US3991756 *Aug 18, 1975Nov 16, 1976Donald SynderMethod and apparatus for intravenous access
US4011861 *Oct 28, 1975Mar 15, 1977Case Western Reserve UniversityImplantable electric terminal for organic tissue
US4015601 *Oct 14, 1975Apr 5, 1977General Atomic CompanyBlood access device
US4025964 *Jul 30, 1976May 31, 1977The United States Of America As Represented By The Administrator Of The National Aeronautics And Space AdministrationMagnetic electrical connectors for biomedical percutaneous implants
US4092983 *Jan 31, 1977Jun 6, 1978General Atomic CompanyBlood access device
US4108173 *Apr 11, 1977Aug 22, 1978General Atomic CompanyBlood access device
US4108174 *Apr 13, 1977Aug 22, 1978General Atomic CompanyCatheter interlock system
US4183357 *Jul 3, 1978Jan 15, 1980Bentley Laboratories, Inc.Chronic transcutaneous implant assembly for enterostomies
US4217664 *Feb 2, 1979Aug 19, 1980Faso Joseph MProsthesis and method for creating a stoma
US4261363 *Nov 9, 1979Apr 14, 1981C. R. Bard, Inc.Retention clips for body fluid drains
US4278092 *Jul 5, 1979Jul 14, 1981American Hospital Supply CorporationPeritoneal catheter
US4307719 *Nov 23, 1979Dec 29, 1981Mcparland Felix AHyperalimentation catheter and method of use
US4321914 *Apr 22, 1980Mar 30, 1982W. L. Gore & Associates, Inc.Percutaneous conduit having PTFE skirt
US4343788 *Jun 29, 1979Aug 10, 1982The Procter & Gamble CompanyAntimicrobial polymer compositions
US4392848 *Jun 25, 1979Jul 12, 1983The Procter & Gamble CompanyCatheterization
US4405319 *Sep 18, 1981Sep 20, 1983Renal Systems, Inc.Porous titanium coating for blood access device
US4417888 *Mar 15, 1982Nov 29, 1983Renal Systems, Inc.Percutaneous implant
US4461281 *Jun 15, 1977Jul 24, 1984Carson Robert WArthroscopic surgical apparatus and method
US4479795 *Jul 27, 1982Oct 30, 1984The Procter & Gamble CompanyFor catheters
US4496349 *Oct 26, 1981Jan 29, 1985Renal Systems, Inc.Percutaneous implant
US4508533 *Jul 14, 1980Apr 2, 1985Daniel AbramsonSurgical drain
US4534760 *Jun 26, 1984Aug 13, 1985Bentley Laboratories, Inc.Angular implant device
US4536893 *Nov 7, 1984Aug 27, 1985Roberto ParraviciniImplant device for substaining the activity of the myocardium
US4579120 *Jan 29, 1985Apr 1, 1986Cordis CorporationStrain relief for percutaneous lead
US4583983 *Oct 25, 1983Apr 22, 1986Einhorn Carol JFemale urinary drainage device
US4588404 *Mar 18, 1982May 13, 1986Didier LapeyreTotal cardiac prosthesis
US4597756 *Apr 19, 1985Jul 1, 1986American Hospital Supply CorpAngular implant device
US4645504 *May 24, 1985Feb 24, 1987The Regents Of The University Of CaliforniaTo minimize or eliminate use of antibiotics; prosthetics
US4654032 *May 13, 1986Mar 31, 1987Morales George HectorDrainage "T" tube used for abdominal surgery
US4676782 *May 13, 1986Jun 30, 1987Vitaphore CorporationPositionable tissue interfacing device for the management of percutaneous conduits
US4676802 *Jan 21, 1986Jun 30, 1987J. Tofield, Et Al.Method and apparatus for securing a prosthesis to the human body
US4753656 *May 15, 1987Jun 28, 1988Tofield Joshua JMethod and apparatus for securing a prosthesis to the human body
US4774817 *Aug 22, 1985Oct 4, 1988June Anne BeamNon-hygroscopic, non-allergenic earring construction
US4776843 *Nov 21, 1980Oct 11, 1988Minntech CorporationBlood access systems
US4781694 *Feb 26, 1986Nov 1, 1988Branemark Per IngvarAbdominal wall pathway
US4813967 *Sep 11, 1987Mar 21, 1989Societe Nationale Industrielle AerospatialeCarbon fibers, biocompatibility
US4834713 *Oct 30, 1987May 30, 1989Best Industries, Inc.Catheter buttons
US4865037 *Nov 13, 1987Sep 12, 1989Thomas J. FogartyMethod for implanting automatic implantable defibrillator
US4886502 *Dec 9, 1986Dec 12, 1989Thermedics, Inc.Peritoneal access catheter
US4959055 *Mar 13, 1989Sep 25, 1990Hillyer Janice LRetainer for a percutaneous tube
US5035711 *Sep 5, 1990Jul 30, 1991Kabushiki Kaisya Advance Kaihatsu KenkyujoComposed Of A Ceramic Material Consisting Of Hydroxyapatite, Tricalcium Phosphate Or Tetracalcium Phosphate
US5098398 *Apr 21, 1987Mar 24, 1992Dan LundgrenImplant passageway
US5120313 *Mar 20, 1990Jun 9, 1992Nancy W. ElftmanMethod for measuring blood pressure in an animal or human using a percutaneous access port
US5167229 *Mar 24, 1986Dec 1, 1992Case Western Reserve UniversityFunctional neuromuscular stimulation system
US5257973 *Feb 5, 1992Nov 2, 1993Raul VillasusoSealing sleeve and method for laparoscopy
US5266071 *Mar 20, 1992Nov 30, 1993Nancy W. ElftmanMethod for using percutaneous accessport
US5425761 *Nov 21, 1990Jun 20, 1995Lundgren; DanImplant with a through passage
US5464446 *Oct 12, 1993Nov 7, 1995Medtronic, Inc.Brain lead anchoring system
US5833664 *Oct 8, 1996Nov 10, 1998Seare, Jr.; William J.Noded cuffs for transcutaneous or intrabody prosthetic devices
US5843150 *Oct 8, 1997Dec 1, 1998Medtronic, Inc.System and method for providing electrical and/or fluid treatment within a patient's brain
US5865842 *Aug 29, 1996Feb 2, 1999Medtronic, Inc.System and method for anchoring brain stimulation lead or catheter
US5882341 *Oct 25, 1996Mar 16, 1999Bousquet; Gerald G.Method of providing a long-lived window through the skin to subcutaneous tissue
US5954758 *Jan 20, 1998Sep 21, 1999Case Western Reserve UniversityFunctional neuromuscular stimulation system
US5971961 *May 21, 1998Oct 26, 1999Seare, Jr.; William J.Noded cuffs for transcutaneous intrabody prosthetic devices
US5971962 *Mar 10, 1998Oct 26, 1999Sun Medical Technology ResearchSkin button
US6026328 *Jan 20, 1998Feb 15, 2000Case Western Reserve UniversityFunctional neuromuscular stimulation system with shielded percutaneous interface
US6099508 *Sep 21, 1998Aug 8, 2000Bousquet; Gerald G.Transcutaneous access device
US6163725 *Jan 20, 1998Dec 19, 2000Case Western Reserve UniversityFunctional neuromuscular stimulation system
US6459917May 22, 2000Oct 1, 2002Ashok GowdaApparatus for access to interstitial fluid, blood, or blood plasma components
US6718210Oct 23, 2000Apr 6, 2004Case Western Reserve UniversityFunctional neuromuscular stimulation system
US6845271May 3, 2002Jan 18, 2005Neurocontrol CorporationTreatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US7604658May 4, 2004Oct 20, 2009Codman & Shurtleff, Inc.Multiple lumen sensor attachment
US7628821Aug 2, 2005Dec 8, 2009Barosense, Inc.Obesity treatment method
US7704225Jul 27, 2006Apr 27, 2010L-Vad Technology, Inc.Percutaneous access device system facilitating cell growth thereon
US7708181Mar 21, 2008May 4, 2010Barosense, Inc.Endoscopic stapling devices and methods
US7721932Mar 21, 2008May 25, 2010Barosense, Inc.Endoscopic stapling devices and methods
US7811257 *Jul 23, 2002Oct 12, 2010Saab Mark AMedical device with adjustable epidermal tissue ingrowth cuff
US7892292Jun 30, 2006Feb 22, 2011Synecor, LlcPositioning tools and methods for implanting medical devices
US7909219Mar 21, 2008Mar 22, 2011Barosense, Inc.Endoscopic stapling devices and methods
US7909222Mar 21, 2008Mar 22, 2011Barosense, Inc.Endoscopic stapling devices and methods
US7909223Mar 21, 2008Mar 22, 2011Barosense, Inc.Endoscopic stapling devices and methods
US7913892Mar 21, 2008Mar 29, 2011Barosense, Inc.Endoscopic stapling devices and methods
US7922062Mar 21, 2008Apr 12, 2011Barosense, Inc.Endoscopic stapling devices and methods
US7934631Nov 10, 2008May 3, 2011Barosense, Inc.Multi-fire stapling systems and methods for delivering arrays of staples
US7935096 *Sep 2, 2005May 3, 2011Ostomycure AsPercutaneous implant
US7976452May 20, 2008Jul 12, 2011L.Vad Technology, Inc.Long term ambulatory intro-aortic balloon pump with percutaneous access device
US7981162Jan 5, 2004Jul 19, 2011Barosense, Inc.Satiation devices and methods
US8020741Mar 18, 2008Sep 20, 2011Barosense, Inc.Endoscopic stapling devices and methods
US8029455Mar 5, 2009Oct 4, 2011Barosense, Inc.Satiation pouches and methods of use
US8109895Aug 31, 2007Feb 7, 2012Barosense, Inc.Intestinal sleeves and associated deployment systems and methods
US8206456May 23, 2006Jun 26, 2012Barosense, Inc.Restrictive and/or obstructive implant system for inducing weight loss
US8241202Apr 22, 2010Aug 14, 2012Barosense, Inc.Restrictive and/or obstructive implant for inducing weight loss
US8249713Nov 5, 2007Aug 21, 2012Spr Therapeutics, LlcTreatment of shoulder dysfunction using a percutaneous intramuscular stimulation system
US8337566Dec 4, 2009Dec 25, 2012Barosense, Inc.Method and apparatus for modifying the exit orifice of a satiation pouch
US8343139Oct 26, 2007Jan 1, 2013Mateen Ahmed APortable pressure relief system and methods
US8383407Feb 13, 2012Feb 26, 2013L-Vad Technology, Inc.Percutaneous access device system facilitating cell growth thereon
US8469977May 21, 2010Jun 25, 2013Barosense, Inc.Endoscopic plication device and method
US8568488Oct 1, 2009Oct 29, 2013Boston Scientific Scimed, Inc.Satiation devices and methods
US8617116Mar 27, 2009Dec 31, 2013Marvao Medical Devices Ltd.Deformable medical implant
US8626302Aug 3, 2009Jan 7, 2014Spr Therapeutics, LlcSystems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
US8647304Feb 28, 2007Feb 11, 2014Ostomycure AsImplant and method for its manufacture
US8747421Apr 18, 2011Jun 10, 2014Boston Scientific Scimed, Inc.Multi-fire stapling systems and methods for delivering arrays of staples
US8784354Feb 22, 2011Jul 22, 2014Boston Scientific Scimed, Inc.Positioning tools and methods for implanting medical devices
US8784500Oct 8, 2004Jul 22, 2014Boston Scientific Scimed, Inc.Devices and methods for retaining a gastro-esophageal implant
US20110178540 *Aug 19, 2008Jul 21, 2011Ostomycure AsPercutaneous abdominal implant
US20110196324 *Apr 18, 2011Aug 11, 2011Ostomycure AsImplant
EP0022370A1 *Jul 7, 1980Jan 14, 1981American Hospital Supply CorporationPeritoneal catheter
EP0039183A1 *Apr 16, 1981Nov 4, 1981W.L. GORE & ASSOCIATES, INC.Percutaneous implant device
EP0081724A1 *Nov 26, 1982Jun 22, 1983Fresenius AGIntraperitoneal catheter
EP0103081A2 *Jun 18, 1983Mar 21, 1984Hti Bio-Products, Inc.Method of growing cells in vitro
EP0120689A2 *Mar 23, 1984Oct 3, 1984Kabushiki Kaisya AdvanceTranscutaneously implantable element
EP0178234A1 *Aug 30, 1985Apr 16, 1986Jean-Jacques RussierPhysiological and tight joint for endo-extracorporeal implantation
EP0271613A1 *Nov 12, 1986Jun 22, 1988Fredric FeitImproved percutaneous sinus tract maintenance prosthesis
EP0864333A2 *Mar 10, 1998Sep 16, 1998Sun Medical Technology Research CorporationSkin button
EP1632201A1 *Sep 6, 2004Mar 8, 2006Ostomycure ASImplant
EP2583642A1 *Oct 21, 2011Apr 24, 2013Universitätsspital BaselImplantable stoma ring
WO1981000052A1 *Jun 26, 1980Jan 22, 1981American Hospital Supply CorpPeritoneal catheter
WO1989003702A1 *Oct 28, 1988May 5, 1989Best Ind IncCatheter buttons
WO1992009314A1 *Nov 21, 1991May 22, 1992Dan LundgrenImplant with a through passage
WO1998015308A1 *Oct 8, 1997Apr 16, 1998Seare William J JrNoded cuffs for transcutaneaous or intrabody prosthetic devices
WO2013057255A1 *Oct 19, 2012Apr 25, 2013Universitaetsspital BaselImplantable stoma ring
Classifications
U.S. Classification623/23.64, 604/175
International ClassificationA61M1/00
Cooperative ClassificationA61M39/0247, A61M2039/0261, A61M2039/0285
European ClassificationA61M39/02T